CTI BioPharma Corp.

Informe acción NasdaqCM:CTIC

Capitalización de mercado: US$1.2b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Salud financiera de hoja de balance de CTI BioPharma

Salud financiera controles de criterios 0/6

CTI BioPharma has a total shareholder equity of $-25.3M and total debt of $116.5M, which brings its debt-to-equity ratio to -459.4%. Its total assets and total liabilities are $112.3M and $137.6M respectively.

Información clave

-459.4%

Ratio deuda-patrimonio

US$116.46m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$59.01m
Patrimonio-US$25.35m
Total pasivoUS$137.62m
Activos totalesUS$112.27m

Actualizaciones recientes sobre salud financiera

Recent updates

CTI BioPharma: Reiterating Target Price Of $17 After Successful VONJO Launch

Aug 17

CTI BioPharma GAAP EPS of -$0.21 misses by $0.01, revenue of $12.33M beats by $3.23M

Aug 08

CTI BioPharma: Approval Is Great, Now There's The Follow Through

Jul 19

CTI BioPharma initiated at outperform at Cowen on potential for Vonjo for myelofibrosis

Jul 07

CTI BioPharma - 3.2x Potential Upside On A De-Risked Asset

May 04

CTI BioPharma Corp.: Pacritinib Approval, Downgrade To A Sell Rating

Apr 11

CTI BioPharma: A Speculative Buy Into The PDUFA Date

Mar 01

CTI BioPharma: Long And Troubled History, Finally Approaching Approval

Dec 24

FDA grants 'priority review' status to CTI Biopharma's pacritinib NDA

Jun 01

CTI BioPharma initiated buy at Stifel; cites potential in myelofibrosis

May 06

CTI BioPharma: Accelerated Approval Pathway Looks Attractive

Dec 06

Análisis de la situación financiera

Pasivos a corto plazo: CTIC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Pasivo a largo plazo: CTIC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historial y análisis de deuda-patrimonio

Nivel de deuda: CTIC has negative shareholder equity, which is a more serious situation than a high debt level.

Reducción de la deuda: CTIC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: CTIC has less than a year of cash runway based on its current free cash flow.

Pronóstico de cash runway: CTIC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.9% each year


Descubre empresas con salud financiera